Adamantinomatous craniopharyngioma: moving toward targeted therapies.
Neurosurg Focus
; 48(1): E7, 2020 01 01.
Article
em En
| MEDLINE
| ID: mdl-31896087
Palavras-chave
ACP = adamantinomatous craniopharyngioma; ERK = extracellular signalregulated kinase; IFN = interferon; IL-6 = interleukin 6; MAPK = mitogen-activated protein kinase; MEK = mitogen extracellular kinase; PD-1 = programmed cell death protein 1; PD-L1 = programmed cell death protein ligand 1; SHH = Sonic Hedgehog; TGF-α = transforming growth factorα; adamantinomatous craniopharyngioma; childhood craniopharyngioma; genetically engineered mouse model; targeted therapies
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Hipofisárias
/
Craniofaringioma
Tipo de estudo:
Prognostic_studies
Limite:
Humans
Idioma:
En
Revista:
Neurosurg Focus
Assunto da revista:
NEUROCIRURGIA
Ano de publicação:
2020
Tipo de documento:
Article